Key Takeaways
- The Pharmacy Council of India (PCI) has approved new pharmacy courses at Indraprastha University (GGSIPU) for the 2024-25 academic year.
- The new courses include D.Pharm, B.Pharm, and M.Pharm in Pharmaceutics, Pharmacology, Phytopharmacy and Phytomedicine, and Pharmaceutical Chemistry.
- The courses will have a total intake of 220 students, with 60 seats for D.Pharm, 100 seats for B.Pharm, and 15 seats for each M.Pharm specialisation.
New Delhi: The Pharmacy Council of India (PCI) has approved several new pharmacy courses at Indraprastha University (GGSIPU), starting from the 2024-25 academic year.
These courses include D.Pharm, B.Pharm, and M.Pharm in Pharmaceutics, Pharmacology, Phytopharmacy and Phytomedicine, and Pharmaceutical Chemistry. This is the first time these courses will be offered on the university campus.
Prof (Dr) Mahesh Verma, Vice Chancellor of GGSIPU, stated that the D.Pharm programme will have 60 seats, B.Pharm 100 seats, and each M.Pharm specialisation 15 seats, totalling an intake of 220 students. Prof Verma stated, “These courses will cater to the need for qualified manpower in the pharmaceutical sector. The teaching pedagogy, hands-on experience with the latest equipment, and industry-friendly approach will be the unique features at the Centre of Excellence in Pharmaceutical Sciences (CEPS).”
Admissions for the D.Pharm programme will be purely based on Class 12th merit lists. For B.Pharm, preference will be given to CET applicants, and any remaining seats will be filled by those who have cleared NEET. M.Pharm seats will prioritise GPAT-qualified candidates, followed by CET applicants.
The demand for Indian pharmaceuticals has surged post-Covid, with India ranking third worldwide in drug and pharmaceutical production by volume, exporting to approximately 200 countries and territories. The Indian pharmaceutical industry, valued at $50 billion, is expected to grow to $65 billion by 2024 and $130 billion by 2030.
The Pharmacy education and profession in India are regulated by the PCI, a statutory body under the Ministry of Health & Family Welfare. The PCI governs pharmacy education through the Pharmacy Act, 1948, which was passed by Parliament to regulate the profession and practice of pharmacy in the country. Presently, India has 2,489 institutes, 101,409 pharmacists, and 91,530 pharmacy faculties in the profession.
CEPS, established by the university in 2014, aims to provide interdisciplinary academic and research activities in the field of pharmacy. It currently offers M.Sc. programmes in Medicinal Chemistry and Drug Design and Bioinformatics, alongside a PhD programme in Pharmaceutical Chemistry. The centre is well-equipped with advanced instruments and staffed by faculty with rich academic backgrounds.
CEPS has also initiated a centralized instrumentation facility with advanced instruments like NMR, SEM, HPLC, GC, Elisa Plate Reader, UV-spectrophotometer, FTIR, and Microwave synthesizer. This facility is available to both academia and industry users at nominal charges.
The new courses at CEPS align with the academic approach of NEP 2020, emphasizing practical implementation of knowledge to skill students for industry or self-employment. “The students are groomed from an industry perspective by reputed scientists from esteemed institutes,” added Prof Verma.
